Karyopharm Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Karyopharm Therapeutics exhibits at Booth 939 at ASH 2026 in New Orleans. Karyopharm Therapeutics supports a symposium on myelofibrosis. Using patient cases, it looks at where treatment stands today and where it is going next.
| Organization | ASH 2026 Attendance |
|---|---|
Karyopharm Therapeutics Newton, MA | |
Commercial-stage cancer drug company whose SINE compounds block the nuclear export protein XPO1, with a focus on blood cancers. | Booth Exhibiting at Booth 939 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies. |
Find decision makers at Karyopharm Therapeutics
Tell us what you sell and we’ll find the people at Karyopharm Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction